Cargando…

Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation

The recurrence of IgA nephropathy (IgAN) after kidney transplantation occurs in 20–35% of patients. The main aim of this study is to evaluate risk factors affecting the course of IgAN after renal biopsy of native kidney and kidney transplant. We evaluated clinical parameters and histological finding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maixnerova, Dita, Hruba, Petra, Neprasova, Michaela, Bednarova, Kamila, Slatinska, Janka, Suchanek, Miloslav, Kollar, Marek, Novak, Jan, Tesar, Vladimir, Viklicky, Ondrej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515028/ https://www.ncbi.nlm.nih.gov/pubmed/34659212 http://dx.doi.org/10.3389/fimmu.2021.726215

Ejemplares similares

Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
por: Neprasova, Michaela, et al.
Publicado: (2023)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study
por: Neprasova, Michaela, et al.
Publicado: (2016)

A novel prognostic nomogram predicts premature failure of kidney allografts with IgA nephropathy recurrence
por: Bednarova, Kamila, et al.
Publicado: (2023)

The coincidence of IgA nephropathy and Fabry disease
por: Maixnerová, Dita, et al.
Publicado: (2013)

Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA Nephropathy
por: Sparding, Nadja, et al.
Publicado: (2023)

Emerging Modes of Treatment of IgA Nephropathy
por: Maixnerova, Dita, et al.
Publicado: (2020)

Expanding options of supportive care in IgA nephropathy
por: Maixnerova, Dita, et al.
Publicado: (2023)

Tuberculosis dissemination in kidney transplant recipient treated with anti-CD40 monoclonal antibody: a case report
por: Bednarova, Kamila, et al.
Publicado: (2022)

Intrarenal Complement System Transcripts in Chronic Antibody-Mediated Rejection and Recurrent IgA Nephropathy in Kidney Transplantation
por: Cernoch, Marek, et al.
Publicado: (2018)

Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis
por: Sparding, Nadja, et al.
Publicado: (2021)

Urine proteomics for prediction of disease progression in patients with IgA nephropathy
por: Rudnicki, Michael, et al.
Publicado: (2020)

New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies
por: Maixnerova, Dita, et al.
Publicado: (2022)

Molecular Fingerprints of Borderline Changes in Kidney Allografts Are Influenced by Donor Category
por: Hruba, Petra, et al.
Publicado: (2020)

Rejection-associated Phenotype of De Novo Thrombotic Microangiopathy Represents a Risk for Premature Graft Loss
por: Petr, Vojtech, et al.
Publicado: (2021)

Predictive Potential of Flow Cytometry Crossmatching in Deceased Donor Kidney Transplant Recipients Subjected to Peritransplant Desensitization
por: Osickova, Klara, et al.
Publicado: (2021)

Author Correction: Molecular patterns of isolated tubulitis differ from tubulitis with interstitial inflammation in early indication biopsies of kidney allografts
por: Hruba, Petra, et al.
Publicado: (2021)

Molecular patterns of isolated tubulitis differ from tubulitis with interstitial inflammation in early indication biopsies of kidney allografts
por: Hruba, Petra, et al.
Publicado: (2020)

SLCO1B1 Polymorphism is not associated with Risk of Statin-Induced Myalgia/Myopathy in a Czech Population
por: Hubáček, Jaroslav A., et al.
Publicado: (2015)

Challenges in IgA Nephropathy Management: An Era of Complement Inhibition
por: Tesař, Vladimir, et al.
Publicado: (2023)

CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation
por: Sekerkova, Alena, et al.
Publicado: (2014)

Why Target the Gut to Treat IgA Nephropathy?
por: Barratt, Jonathan, et al.
Publicado: (2020)

Comparison of COVID-19 epidemic among Czech dentists and the Czech general population
por: Schmidt, Jan, et al.
Publicado: (2023)

MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy
por: Petr, Vojtech, et al.
Publicado: (2022)

The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
por: Knoppova, Barbora, et al.
Publicado: (2016)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

The incidence and prevalence of IgA nephropathy in Europe
por: Willey, Cynthia J, et al.
Publicado: (2023)

Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA – associated vasculitis
por: Satrapova, Veronika, et al.
Publicado: (2023)

International Physicians Delphi Survey: Managing Patients With IgA Nephropathy
por: Floege, Jürgen, et al.
Publicado: (2022)

Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
por: Reily, Colin, et al.
Publicado: (2014)

Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls
por: Sanders, John T., et al.
Publicado: (2017)

Special Issue: New Insights into the Pathogenesis and Therapies of IgA Nephropathy
por: Suzuki, Hitoshi, et al.
Publicado: (2022)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis
por: Kiryluk, Krzysztof, et al.
Publicado: (2012)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy
por: Takahashi, Kazuo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jlhrttnkporshjb07v91e43m5i